Rectal Carcinoma Clinical Trial
Official title:
Resource-Sparing Curative Treatment for Rectal Cancer
This is a prospective, multicentre, randomized clinical trial comparing two different
neo-adjuvant radiation-based strategies prior to intended surgery for locally advanced
adenocarcinoma of the rectum.
This trial may establish the investigational therapy to be superior to, or at least not
inferior to conventional treatment.
This phase III randomised clinical trial compares the outcome of two different neo-adjuvant
radiation based treatments for locally advanced rectal carcinoma. This encompasses patients
at risk for a positive circumfrential resection margin (CRM+) on baseline assessment imaging
and pateints identified as being with a T-descriptor T4 at baseline assessment.
The arms compared are as follows:
- The investigational arm: short chemo-radiation course(25Gy in 5 daily fractions over 1
week) +/- surgery.
- The conventional arm: protracted chemo-radiation course (50Gy in 25 daily fractions
over 5 weeks combined with chemotherapy)+/- surgery.
The outcomes include four domains: overall survival, biological effect, quality of life and
health-related economics.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01227239 -
Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting
|
Phase 1/Phase 2 | |
Recruiting |
NCT04078828 -
PR in Endoscopic LAR for Rectal Cancer
|
N/A | |
Not yet recruiting |
NCT06424522 -
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
|
Early Phase 1 | |
Terminated |
NCT02797405 -
Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay
|
N/A | |
Completed |
NCT01751516 -
PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study
|
||
Terminated |
NCT01111292 -
Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia
|
Phase 1/Phase 2 | |
Completed |
NCT00682786 -
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
|
Phase 2 | |
Completed |
NCT02000050 -
Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)
|
Phase 2 | |
Recruiting |
NCT04749108 -
Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT01696981 -
Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)
|
N/A | |
Active, not recruiting |
NCT01899547 -
Laparoscopy-Assisted Surgery for Carcinoma of the Low Rectum
|
N/A | |
Completed |
NCT01333709 -
Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma
|
Phase 2 | |
Recruiting |
NCT04848311 -
Indocanine Green as Tracer for Lymph Nodes Dissection in Station 253
|
N/A | |
Not yet recruiting |
NCT02770911 -
Laparoscopic Anterior Resection With or Without "Dog Ear" Double-stapled Anastomosis for Rectal Cancer
|
Phase 3 | |
Active, not recruiting |
NCT02432963 -
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy
|
Phase 1 | |
Active, not recruiting |
NCT04505553 -
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
|
Phase 2 | |
Completed |
NCT01372007 -
Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma
|
Phase 3 | |
Active, not recruiting |
NCT02817126 -
Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer
|
N/A | |
Completed |
NCT02551237 -
Neoadjuvant Treatment for Advanced Rectal Carcinoma
|
Phase 3 | |
Active, not recruiting |
NCT04713618 -
Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy
|